Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
NCT01414309 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2015-01-07
Summary
Central sleep apnea (CSA) has been associated with increased mortality and primarily occurs in patients with heart failure (HF). The primary purpose of this study is to document the natural progression of moderate to severe CSA in heart failure patients.
Conditions
- Central Sleep Apnea
- Heart Failure
Sponsors & Collaborators
-
Respicardia, Inc.
lead INDUSTRY
Principal Investigators
-
Robin Germany, M.D. · Respicardia, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2012-06-30
- Completion
- 2012-06-30
Countries
- United States
- Germany
Study Locations
More Related Trials
-
The Epidemiology of Sleep Disordered Breathing in Patients With Congestive Heart Failure
NCT05332223 ·Status: COMPLETED
-
The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart Disease
NCT02059993 ·Status: COMPLETED ·Phase: NA
-
Treatment of Central Sleep Apnoea in Patients With Heart Failure With Nasal High Flow Therapy (nHFT)
NCT03085641 ·Status: TERMINATED ·Phase: NA
-
Heart Function in Patients Assessed for Sleep Apnoea
NCT03226652 ·Status: COMPLETED
-
Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index
NCT03062748 ·Status: ENROLLING_BY_INVITATION
-
Sleep Apnea in Heart Failure With Preserved Ejection Fraction
NCT05008432 ·Status: COMPLETED
-
Prognostic Impact of Sleep Apnea on Cardiovascular Morbidity and Mortality, in End Stage Renal Disease Patients
NCT02073305 ·Status: UNKNOWN
-
Effectiveness of the Treatment With Continuous Positive Airway Pressure(CPAP)in Stable Heart Failure With Ejection Fraction More Than 45% and Sleep Disordered Breathing
NCT01347411 ·Status: COMPLETED ·Phase: NA
-
"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"
NCT01317329 ·Status: COMPLETED ·Phase: NA
-
Benefit of Cheyne-Stokes Respiration Remote Monitoring in CPAP-treated Patients With Obstructive Sleep Apnea to Detect Early Events of Heart Failure.
NCT03592108 ·Status: COMPLETED ·Phase: NA
-
PRevalence, Persistence and prOgnostic ValuE of Sleep Apnea Syndrome in Acute Heart Failure
NCT02317848 ·Status: COMPLETED ·Phase: NA
-
The Role of Sleep Apnea in the Acute Exacerbation of Heart Failure
NCT00679549 ·Status: COMPLETED ·Phase: NA
-
Potential Mechanism of Exercise Impairment in OSA
NCT02505594 ·Status: COMPLETED
-
Effects of Nocturnal Nasal Oxygen on Biomarkers in Sleep Apnea Patients With Heart Failure
NCT01431157 ·Status: TERMINATED ·Phase: NA
-
Chronic Evaluation of Respicardia Therapy
NCT01124370 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Influence of Apnea on Cardiac Function Using Cardiac Magnetic Resonance Imaging.
NCT02280226 ·Status: COMPLETED ·Phase: NA
-
Fluid Shift on Obstructive and Central Sleep Apnea
NCT02349997 ·Status: COMPLETED
-
Sleep Apnea Intervention for Cardiovascular Disease Reduction
NCT01261390 ·Status: COMPLETED ·Phase: NA
-
Initiation of CPAP for Newly Diagnosed OSA in Hospitalized Heart Failure Patients
NCT03056443 ·Status: COMPLETED ·Phase: NA
-
Sleep Apnea in a Non-Clinical Population
NCT00005551 ·Status: COMPLETED
-
Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea
NCT01475682 ·Status: UNKNOWN
-
Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH)
NCT01835080 ·Status: TERMINATED
-
Sleep Apnea in Early to Mid-Stage Alzheimer's Disease
NCT01400542 ·Status: TERMINATED
-
Evaluation of Association Between Obstructive Sleep Apnea and the Severity of Coronary Artery Disease
NCT03066141 ·Status: COMPLETED
-
The Severity Of Individual Breathing Cessation Events In Diagnostics Of Obstructive Sleep Apnea
NCT03232658 ·Status: UNKNOWN